Freedman Lori bought ORGO
February 18, 2026 · Form 4 insider transaction
Freedman Lori bought 115,812 shares of Organogenesis Holdings Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
115,812
Price
$0.00
Total value
N/A
InsiderFreedman Lori
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 18, 2026
Filing dateFebruary 20, 2026
Shares owned after115,812
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option becomes exercisable in equal annual installments over four years beginning February 15, 2026.